Cargando…

A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency

Antiretroviral therapy for HIV-1 infection/AIDS has significantly extended the life expectancy of HIV-1-infected individuals and reduced HIV-1 transmission at very high rates. However, certain individuals who initially achieve viral suppression to undetectable levels may eventually suffer treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoki, Manabu, Hayashi, Hironori, Rao, Kalapala Venkateswara, Das, Debananda, Higashi-Kuwata, Nobuyo, Bulut, Haydar, Aoki-Ogata, Hiromi, Takamatsu, Yuki, Yedidi, Ravikiran S, Davis, David A, Hattori, Shin-ichiro, Nishida, Noriko, Hasegawa, Kazuya, Takamune, Nobutoki, Nyalapatla, Prasanth R, Osswald, Heather L, Jono, Hirofumi, Saito, Hideyuki, Yarchoan, Robert, Misumi, Shogo, Ghosh, Arun K, Mitsuya, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2017
Materias:	Microbiology and Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644950/ https://www.ncbi.nlm.nih.gov/pubmed/29039736 http://dx.doi.org/10.7554/eLife.28020

Ejemplares similares

GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants
por: Aoki, Manabu, et al.
Publicado: (2023)

Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
por: Bulut, Haydar, et al.
Publicado: (2020)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Hattori, Shin-ichiro, et al.
Publicado: (2020)

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Hattori, Shin-ichiro, et al.
Publicado: (2021)

Identification of SARS-CoV-2 M(pro) inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
por: Higashi-Kuwata, Nobuyo, et al.
Publicado: (2023)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro
por: Amano, Masayuki, et al.
Publicado: (2017)

Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent
por: Kumamoto, Hiroki, et al.
Publicado: (2023)

Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
por: Harada, Keisuke, et al.
Publicado: (2014)

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes
por: Takamatsu, Yuki, et al.
Publicado: (2023)

Regulation of Retroviral and SARS-CoV-2 Protease Dimerization and Activity through Reversible Oxidation
por: Davis, David A., et al.
Publicado: (2022)

Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
por: Aoki, Manabu, et al.
Publicado: (2018)

Glyceraldehyde 3-phosphate dehydrogenase negatively regulates human immunodeficiency virus type 1 infection
por: Kishimoto, Naoki, et al.
Publicado: (2012)

The C-terminal domain of glyceraldehyde 3-phosphate dehydrogenase plays an important role in suppression of tRNA(Lys3) packaging into human immunodeficiency virus type-1 particles
por: Kishimoto, Naoki, et al.
Publicado: (2016)

Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s
por: Nakata, Hirotomo, et al.
Publicado: (2019)

Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1
por: Misumi, Shogo, et al.
Publicado: (2010)

Royal jelly enhances antigen‐specific mucosal IgA response
por: Kai, Hikaru, et al.
Publicado: (2013)

Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration
por: Kishimoto, Naoki, et al.
Publicado: (2020)

Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core
por: Kishimoto, Naoki, et al.
Publicado: (2021)

Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine
por: Amano, Masayuki, et al.
Publicado: (2022)

AAA-ATPases in Protein Degradation
por: Yedidi, Ravikiran S., et al.
Publicado: (2017)

ATP generation in a host cell in early-phase infection is increased by upregulation of cytochrome c oxidase activity via the p2 peptide from human immunodeficiency virus type 1 Gag
por: Ogawa, Minako, et al.
Publicado: (2015)

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
por: Davis, David A., et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron
por: Amano, Masayuki, et al.
Publicado: (2023)

X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design
por: St. John, Sarah E., et al.
Publicado: (2015)

Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation
por: Higashi-Kuwata, Nobuyo, et al.
Publicado: (2022)

Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
por: Takamatsu, Yuki, et al.
Publicado: (2022)

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
por: Davis, David A., et al.
Publicado: (2021)

Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
por: Higashi-Kuwata, Nobuyo, et al.
Publicado: (2010)

Unprecedented
Publicado: (1898)

Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application
por: Hayashi, Sanae, et al.
Publicado: (2022)

Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
por: Amano, Masayuki, et al.
Publicado: (2019)

Unprecedented Events do not Always Call for Unprecedented Actions
por: Shrivastava, Deepak
Publicado: (2020)

Nanoparticles of folic acid‐methyl‐β‐cyclodextrin (FA‐MβCD)/adamantane‐albumin exhibit enhanced antitumor activity compared with FA‐MβCD alone
por: Sakai, Aiko, et al.
Publicado: (2022)

Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CL(pro)): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS
por: Tomar, Sakshi, et al.
Publicado: (2015)

Unprecedented Fine Structure of a Solar Flare Revealed by the 1.6 m New Solar Telescope
por: Jing, Ju, et al.
Publicado: (2016)

A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”
por: Tateishi, Hiroshi, et al.
Publicado: (2017)

The unprecedented era of aging
por: Sato, Yuki, et al.
Publicado: (2019)

Unprecedented Times and Innovation
por: Major, Claire
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9dahe291c8eh9noe95jj676eli